Abstract
Fluoroquinolones may provide a useful tool for tackling the growing problem of nosocomial infections in the ICU. This class of antibacterials offers many advantageous properties for use in selective decontamination of the digestive tract and, indeed, fluoroquinolone-containing regimens have been shown to provide protection against infection in this setting. This approach, and other issues relating to fluoroquinolone use in the ICU, were discussed at the 5th International Symposium on New Quinolones [Singapore; August 1994].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
